The GSK share price has been in a strong freefall after peaking at 1,785p in September. Most recently, the GSK stock ...

The GSK (LSE:GSK) share price has fallen off its perch. So it may be a good time to research and consider the stock ...

The GSK share price has tumbled recently on a number of factors, but I think its fundamentals look strong, leaving the stock ...

Shares of GSK plc (NYSE:GSK – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the ten research firms that are covering the stock, Marketbeat.com reports. Seven ...

That’s no longer the case. Today’s trailing yield of 4.34% is okay, but it’s been artificially pumped up by recent share ...

The user of the website is referred to as "you" and "your". By posting on our share chat boards you are agreeing to the following: If you are going to post non-English, please also post an English ...

What was Glaxosmithkline Pharmaceuticals Ltd share price previously? Glaxosmithkline Pharmaceuticals Ltd share price was down by 0.18% from the previous closing price of ₹2,452.70. Who are peers ...

GSK Plc said its blood cancer drug significantly reduced the risk of death when combined with another cancer treatment, ...

In the third quarter, GSK saw weaker-than-expected sales for its respiratory syncytial virus (RSV) and shingles vaccines.

The GSK share price has tumbled recently on a number of factors, but I think its fundamentals look strong, leaving the stock undervalued right now. When investing, your capital is at risk.

The GSK share price rose slightly after the company announced positive result for its linerixibat, a drug that will be used to treat relentless itching caused by primary biliary cholangitis (PBC).